Europe · all countries · model A — Open prescription market

Medical cannabis in Germany

Established access, mostly paid for by the patient

Flower, extracts and finished medicines can all be prescribed — but since 30 July 2026 most patients have had to pay for them themselves.

The hardest fact about Germany. Since 30 July 2026 dried cannabis flower has been excluded from reimbursement by the statutory health insurers. Anyone who stays on it pays privately — even with an old, open-ended approval.

Every answer below was read in the law, the register or the official statistic itself. This country is also covered in full in the German edition of the site.

The questions, answered for Germany

How access works here

The one-line answer: can a new patient start today, and through what.

A — open prescription market. Since 1 April 2024 medical cannabis (including flower) is an ordinary prescription-only medicine under the Medizinal-Cannabisgesetz (MedCanG, Medical Cannabis Act); any physician may prescribe it on a normal prescription and a large self-pay telemedicine/mail-order layer has grown around it.

The Cannabisgesetz (CanG) of 27 March 2024 (BGBl. 2024 I Nr. 109) took cannabis for medical purposes out of the Betäubungsmittelgesetz (BtMG, Narcotics Act) and re-regulated it in the MedCanG, in force 1 April 2024. The government's own bill of 3 December 2025 states the current position: 'Cannabis zu medizinischen Zwecken ist seitdem ein verschreibungspflichtiges Arzneimittel, das auf einem Arzneimittelrezept verschrieben werden kann' (an ordinary medicines prescription, no narcotic form), and describes telemedicine platforms through which flower is obtained 'ohne jeglichen bzw. ohne persönlichen Arzt-Patienten-Kontakt' and shipped by cooperating mail-order pharmacies; imports of flower rose 170 % between H1 and H2 2024 while GKV-reimbursed flower prescriptions rose only 9 %. The BMG FAQ (Stand 4 Sept 2026) confirms 'Medizinalcannabis darf weiter nach den geltenden sozialversicherungsrechtlichen Voraussetzungen als Arzneimittel verschrieben werden.' Statutory insurance reimbursement is the gate, not the prescription itself (see “What is changing” below).

Source: Deutscher Bundestag, Drucksache 21/3061 — Entwurf eines Ersten Gesetzes zur Änderung des Medizinal-Cannabisgesetzes (bill amending the Medical Cannabis Act), 3 Dec 2025 · read 27 September 2026

What may be prescribed

What the law allows a doctor to write on a prescription here.

Dried flower, extracts of standardised quality, dronabinol, nabilone and the finished medicines Sativex, Canemes and Epidyolex.

Since 1 April 2024, cannabis for medical purposes has no longer been governed by the Betäubungsmittelgesetz (Narcotic Drugs Act) but by the MedCanG (Medical Cannabis Act).

Source: MedCanG, Gesetz über den Umgang mit Medizinalcannabis · read 4 September 2026

Who may prescribe

Whether you need a specialist, and whether anyone has to approve it first.

Any doctor — except dentists and vets. There is no restriction to a medical specialty and no additional qualification.

There is no state register of doctors who prescribe cannabis. Anyone selling you a “verified list of doctors” is verifying nothing that the state verifies.

Type of prescription

The form itself: which prescription, how long it is valid, how much it covers.

An ordinary prescription, not a Betäubungsmittelrezept (narcotics prescription) — since cannabis was taken out of the BtMG on 1 April 2024.

For people with statutory insurance but no approval, and for those paying themselves, it is a private prescription. One exception remains: nabilone (Canemes) is still prescribed on a Betäubungsmittelrezept.

Telemedicine

Whether a prescription can lawfully begin in a video call.

Permitted, but politically contested: a draft law would require an initial in-person consultation and ban the mail-order dispatch of flower.

First Act amending the MedCanG, BT-Drs. 21/3061 of 3 December 2025 — first reading on 18 December 2025, public hearing on 14 January 2026, with the health committee ever since, without a second or third reading. It would change § 3 MedCanG (Abs. 2 in-person contact, Abs. 3 a dispatch ban for flower; pharmacy courier delivery would stay permitted). No transition period is foreseen — the act would enter into force the day after promulgation.

Source: BT-Drs. 21/3061 (Deutscher Bundestag) · read 4 September 2026

Dispensing

Which pharmacy can actually hand it over.

Through pharmacies — over the counter, by pharmacy courier and, for now, still by mail order.

Which pharmacy is legally allowed to ship is recorded in the Versandhandels-Register (mail-order register) of the Federal Institute for Drugs and Medical Devices (BfArM). We check every mail-order pharmacy we list against that entry.

Source: BfArM Versandhandels-Register (vhr-apo.pdf) · read 4 September 2026

Reimbursement

Whether anyone other than you pays for it.

Flower: no. Extracts of standardised quality, dronabinol and nabilone: still possible where the conditions of § 31 Abs. 6 SGB V are met.

Changed by the GKV-Beitragssatzstabilisierungsgesetz, promulgated on 29 July 2026 (BGBl. 2026 I Nr. 228), in force since 30 July 2026. Approvals granted earlier are not grandfathered.

Source: ABDA: Neue Regeln für Cannabisarzneimittel in Kraft · read 4 September 2026

What it costs

What you pay, as far as anyone publishes it.

Paying yourself is the rule. On top of the therapy come the doctor's or the platform's fees and the pharmacy price.

Medicine prices appear as the per-gram range the pharmacy shops themselves show; alongside, the fees the providers publish — with source and date checked.

Driving

The question with the worst consequences and the least reliable information online.

Patients are exempt from the THC limit — but not from criminal liability if they are in fact unfit to drive.

§ 24a Abs. 4 StVG exempts use as directed under a medical prescription from the administrative offence. §§ 315c/316 StGB and the driving licence authority (§§ 13a, 14 FeV) are untouched by it.

Source: § 24a StVG · read 4 September 2026

Travel

Taking it across a border, which is where most published advice is simply wrong.

For Schengen states: a certificate under Article 75 of the Schengen Convention (SDÜ), issued by the doctor and authenticated by the supreme health authority of the federal state.

Source: BfArM: Reisen mit medizinischem Cannabis · read 4 September 2026

As a visitor or new resident

Four things nobody publishes together: getting a prescription as a non-resident, using a prescription from another EU country, bringing your own medicine in, and whether a foreign video consultation counts.

German law sets no residency or nationality condition for a cannabis prescription, but you need a German doctor: a prescription written in another EU country is recognised in principle in Germany, yet no official source says pharmacies will fill a foreign cannabis prescription, so do not count on it. Bringing your own medicine for up to 30 days is allowed with a Schengen Article 75 certificate (Schengen residents); travellers from outside Schengen need a multilingual doctor's certificate.

1. Non-residents: MedCanG § 3 requires only a physician's prescription (the government bill describes it as an 'Arzneimittelrezept'); no residency, insurance-number or identity condition is imposed by the act — a private (self-pay) paper prescription is possible for anyone, while the GKV e-prescription route requires German statutory insurance. No official page addresses non-resident patients ('not published'). 2. Prescriptions from another EU/EEA state: Germany transposed Directive 2011/24/EU Art. 11 into the Arzneimittelverschreibungsverordnung (AMVV, prescription ordinance, § 2 Abs. 1a — text could not be opened this session); Art. 11(6) of the Directive lets states exclude 'medicinal products subject to special medical prescription'. Because cannabis left the BtMG on 1 April 2024, the German narcotic-prescription form (Betäubungsmittelrezept, BtMVV § 8) no longer applies to it, so the formal bar that blocks foreign narcotic prescriptions does not automatically block foreign cannabis prescriptions — but whether a German pharmacy may or will dispense cannabis on a foreign prescription is not published by BfArM or BMG ('not published'); pharmacies may refuse a prescription they cannot verify. 3. Bringing medicine in: BfArM — for trips up to 30 days within Schengen, carry 'a certificate issued in accordance with Article 75 of the Schengen Implementing Convention', one per medicine, completed by the treating physician and authenticated by the competent health authority of the Land; the same rules apply to persons entering Germany from Schengen states, who may bring drugs 'that may be prescribed in the country of residence but are not prescribable in the Federal Republic of Germany'; outside Schengen BfArM points to INCB guidance (multilingual certificate with individual and daily dosage, INN, duration of journey, authenticated by the state authority). BfArM's cannabis page stresses that although cannabis is no longer a Betäubungsmittel in Germany, most Schengen states still treat it as one, so a certified travel certificate is still generally needed. Quantity/day rule for non-Schengen visitors entering Germany: not published on the pages opened (customs page could not be fetched). 4. Foreign telemedicine prescription: same as 2 — not officially addressed; a German-issued private prescription after a video consultation is currently lawful, but the pending MedCanG amendment (see “What is changing” below) would require in-person contact for flower.

Source: BfArM (Federal Institute for Drugs and Medical Devices) — Travelling with narcotic drugs (Schengen Art. 75 certificate; entry into Germany) · read 27 September 2026

What is changing

What is pending in parliament or at the regulator, with dates — or the statement that nothing is.

Two things. Already in force: since the end of July 2026 statutory health insurance (GKV) no longer pays for cannabis flower — only standardised extracts and dronabinol/nabilone medicines remain reimbursable. Pending: a government bill would ban mail-order delivery of flower and require an in-person doctor visit before the first flower prescription; whether it has been enacted by 27 September 2026 could not be verified on official pages.

(1) GKV-Beitragssatzstabilisierungsgesetz (statutory-insurance contribution-rate stabilisation act), BGBl. 2026 I Nr. 228 — Bundestag 2nd/3rd reading and Bundesrat 10 July 2026; the BMG law page gives entry into force as 30.07.2026 while the BMG cannabis FAQ says 'Seit dem Inkrafttreten … am 29. Juli 2026 können Cannabisblüten in unverändertem Zustand sowie in Zubereitungen nicht mehr zu Lasten der gesetzlichen Krankenversicherung verordnet werden. Verordnungsfähig nach § 31 Absatz 6 SGB V ist weiterhin Cannabis in Form von Extrakten in standardisierter Qualität und Arzneimittel mit den Wirkstoffen Dronabinol oder Nabilon.' (2) Entwurf eines Ersten Gesetzes zur Änderung des Medizinal-Cannabisgesetzes, Gesetzentwurf der Bundesregierung, BT-Drs. 21/3061 of 3 Dec 2025: new § 3(2) MedCanG — flower 'dürfen nur nach einem persönlichen Kontakt zwischen der Patientin oder dem Patienten und der verschreibenden Ärztin oder dem verschreibenden Arzt in ihrer oder seiner Arztpraxis oder im Rahmen eines Hausbesuches … verschrieben werden'; repeat prescriptions need an in-person contact within the preceding four calendar quarters (a colleague in the same practice may repeat); mail-order dispatch of flower to patients is prohibited; entry into force the day after promulgation. Parliamentary status as of 27 Sept 2026 is NOT verified here: the BMG FAQ dated 4 Sept 2026 does not mention the new rules and no promulgation was found on the pages opened (DIP and BGBl search are not fetchable).

Source: Bundesministerium für Gesundheit (Federal Ministry of Health) — FAQ Cannabisgesetz, Medizinalcannabis section, Stand 4 Sept 2026 · read 27 September 2026

Number of patients

How many people this actually concerns — where anyone counts.

Not published

Around 800,000 — an industry estimate, not an official figure.

There has been no official patient statistic since the Begleiterhebung (the accompanying survey) was discontinued. The figure in circulation is extrapolated from import volumes.

Germany in numbers — the data layer behind these answers

The cards behind these numbers — one per pharmacy, product, producer, city and Land — exist in German only; the English edition carries the country-level summaries.

What we can publish for Germany, and what we cannot

Four directories, four honest answers. Where an official register exists we republish it and link every entry back to the source. Where none exists, that is what the page says — a list built out of self-declarations would be worse than no list, and saying so is more useful to you than pretending.

Doctors

Directory published

There is no register of cannabis-prescribing doctors in Germany, so this is a two-source check rather than a list: the practice names the therapy on its own website, and either a Kassenärztliche Vereinigung or the Ärztekammer named in its Impressum under § 5 DDG evidences that a licensed doctor stands behind it.

Open the doctors directory

Pharmacies

Directory published

Built from the BfArM mail-order register itself and then checked live against each pharmacy's own Impressum. The register entry number travels with the record.

Register: BfArM Versandhandels-Register · read 4 September 2026

Open the pharmacies directory

Products and preparations

Directory published

Germany has no official product list, because a cannabis flower dispensed here is not an authorised medicine but a starting material the pharmacy compounds into a Rezepturarzneimittel — so BfArM has nothing to list. The one identifier that exists across the whole supply chain is the Pharmazentralnummer, an article number issued by a private clearing house, and every entry in our catalogue is bound to one, with the article record we read linked from the row. That is a compilation, not a register, and the page says so in its own first paragraph.

Limit we hold ourselves to: Medicine prices only as the per-gram range the pharmacy shops themselves show, with no ranking. § 10 Abs. 1 HWG forbids advertising prescription-only medicines to the public, and the BGH held on 26 March 2026 (I ZR 74/25) that naming the class together with its indications can be enough to engage it — hence no effect words, indications, ratings or terpene figures: a PZN is an article number, and the cannabinoid figure in an article name is a nominal declaration that the pharmacopoeia itself allows a batch to depart from — ±10 % relative above 15 % content, ±1.5 % absolute below it.

Open the products and preparations directory

Telemedicine platforms

Directory published

Legal entity, register number and register court taken from each platform's own Impressum and matched against the Handelsregister. No ranking, no referral, no commercial relationship.

Open the telemedicine platforms directory

Where this country's law lives

Everything above comes from these texts rather than from another portal's summary. They are listed so you can check us.

Crossing a border with this

Two European rules decide most of what a traveller asks. Directive 2011/24/EU obliges pharmacies to honour prescriptions from another Member State — but only for medicines authorised in the dispensing country, and its Article 11(6) says the rule “shall not apply to medicinal products subject to special medical prescription”, which is where narcotic prescriptions sit. A magistral cannabis preparation is neither authorised nor outside that exclusion, so a cannabis prescription from another country is, as a rule, not dispensable anywhere in Europe. For carrying your own medicine, Article 75 of the Schengen Convention lets a resident of a Schengen state travel with a certified supply for up to 30 days; outside Schengen, national import rules apply. The country-specific answer is above under “As a visitor or new resident”.

Directive 2011/24/EU, Article 11(1) and 11(6) — read on EUR-Lex on 27 September 2026: CELEX 32011L0024.

The same questions, elsewhere

The answers change at every border, and a prescription does not travel with you. Compare before you assume.